MedPath

重庆希韦医药科技有限公司

Ownership
-
Established
2021-08-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Letermovir Tablets

Product Name
来特莫韦片
Approval Number
国药准字H20254189
Approval Date
May 20, 2025
NMPA

Isavuconazonium Sulfate for Injection

Product Name
注射用硫酸艾沙康唑
Approval Number
国药准字H20254057
Approval Date
Apr 30, 2025
NMPA

Metformin Hydrochloride and Empagliflozin Tablets(Ⅰ)

Product Name
二甲双胍恩格列净片(Ⅰ)
Approval Number
国药准字H20249711
Approval Date
Dec 6, 2024
NMPA

Metformin Hydrochloride and Empagliflozin Tablets(Ⅵ)

Product Name
二甲双胍恩格列净片(Ⅵ)
Approval Number
国药准字H20249712
Approval Date
Dec 6, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.